Simultaneously Targeting Obesity and Pain: The STOP Trial
STOP
A Randomized Clinical Trial of an Integrated Behavioral Self-management Intervention Simultaneously Targeting Obesity and Pain: The STOP Trial
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to determine whether an integrated behavioral treatment approach can help overweight or obese individuals who also have chronic pain reduce their weight and manage their pain symptoms. The goal of this research is to develop better treatments for individuals with chronic pain and overweight or obesity. All participants in this study will receive treatment for weight management and/or pain symptoms. Participants will be assigned at random (like we picked it blindly out of a hat) to receive either: (1) Standard behavioral treatment for weight loss; or (2) Standard behavioral treatment for pain management; or (3) Integrated behavioral treatment for weight loss and pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2014
CompletedFirst Posted
Study publicly available on registry
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedApril 15, 2016
April 1, 2016
March 24, 2014
April 13, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Change in weight from baseline to 12-months
Body weight measured using a calibrated digital scale during assessment visits.
Baseline, up to 12 months
Change in pain intensity from baseline to 12 months
Pain intensity as measured on a numeric ratings scale (NRS) of 0 (no pain) to 10 (worst pain imaginable).
Baseline, up to 12 months
Secondary Outcomes (2)
Change in pain disability from baseline to 12 months
Baseline, up to 12 months
Change in quality of life from baseline to 12 months
Baseline, up to 12 months
Study Arms (3)
STOP Intervention
EXPERIMENTALThe STOP treatment includes content designed to simultaneously and explicitly target both chronic pain and obesity. Treatment components are drawn from evidence-based interventions for chronic pain and obesity, separately.
Standard Care Weight (SCW)
ACTIVE COMPARATORThe weight loss intervention includes content focused around nutrition and eating habits, stimulus control and behavioral change, and physical activity. This content has been chosen because of its demonstrated effectiveness and importance in behavioral interventions to reduce weight.
Standard Care Pain (SCP)
ACTIVE COMPARATORThe chronic pain intervention is focused around reconceptualization of pain, decreasing catastrophizing, and increasing self-efficacy for pain. This content has been chosen because of its demonstrated effectiveness and importance in non-pharmacological interventions to improve pain management.
Interventions
Eligibility Criteria
You may qualify if:
- Adults aged ≥ 18
- Body mass index (BMI) ≥ 25
- Chronic, non-cancer pain (pain at a level ≥ 4 on a scale of 0-10 on a majority of the days for 6 months or more prior to study participation)
You may not qualify if:
- Have an unstable medical or psychiatric condition
- Meet criteria for current substance abuse or dependence
- Meet the criteria for bulimia
- Non-fluent in spoken or written English
- Currently pregnant, pregnant within the past 6 months, trying to get pregnant in the next 3 months
- Demonstrate significant cognitive or sensorimotor impairment precluding treatment engagement
- Already participating in a similar structured diet or exercise program or pain self-management program or plans to begin such a program outside the study during the next month
- At risk for significant adverse cardiovascular events with moderate activity
- Plans to relocate within the upcoming 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of the Sciences
Philadelphia, Pennsylvania, 19104, United States
Related Publications (1)
Janke EA, Fritz M, Hopkins C, Haltzman B, Sautter JM, Ramirez ML. A randomized clinical trial of an integrated behavioral self-management intervention Simultaneously Targeting Obesity and Pain: the STOP trial. BMC Public Health. 2014 Jun 18;14:621. doi: 10.1186/1471-2458-14-621.
PMID: 24943851DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth A Janke, PhD
University of the Sciences in Philadelphia
Central Study Contacts
Research Assistant(s)
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychology
Study Record Dates
First Submitted
March 24, 2014
First Posted
April 1, 2014
Primary Completion
January 1, 2017
Last Updated
April 15, 2016
Record last verified: 2016-04